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ABSTRACT 
A blood oxygenator includes an integral pneumatic pump 
disposed substantially Within a housing thereof, an inlet blood 
?ow redirector, and an out?ow blood collector. An atrium 
provided at an inlet of the oxygenator promotes even delivery 
of blood to the oxygenator. In use, the oxygenator provides an 
even dispersion of blood therethrough, establishing even per 
fusion and reducing areas of stagnant blood ?oW. 
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EVEN PERFUSION PUMP-INTEGRATED 
BLOOD OXYGENATOR 
This application claims the bene?t of priority in Us. Pro 
visional Patent Application Ser. Nos. 61/522,411 ?led on 
Aug. 11, 2011 and 61/651,164 ?led on May 24, 2012, the 
entirety of the disclosures of each of which are incorporated 
herein by reference. 
TECHNICAL FIELD 
The present invention relates generally to the ?eld ofmedi 
cal devices. In particular, the invention relates to a pump 
integrated blood oxygenator for use in arti?cial lung (AL) 
applications. 
BACKGROUND OF THE INVENTION 
Conventional arti?cial lung/gas exchanger/oxygenators 
include at least a body, often de?ning a cylinder, a blood inlet, 
one or more blood outlets, and a gas (oxygen) supply inlet and 
outlet. The interior of such devices includes a plurality of 
hollow membrane ?bers whose porosity allows passage of 
gases such as oxygen and C02, but not of liquid, blood cells, 
blood proteins, etc. Gas in?ow/out?ow ports are provided, 
typically in ?uid communication with one another via the 
lumens of the hollow membrane ?bers, Using one or more 
pumps or potentially the patient’s own heart pumping action, 
blood ?ow is established whereby oxygen-depleted and C02 
enriched blood is removed from a patient’s bloodstream, 
passes into the device via the blood inlet, passes over exterior 
surfaces of the hollow membrane ?bers, and exits the device 
through the blood outlet. During this traversal, oxygen passes 
from the hollow ?ber lumens into the blood, and CO2 is 
removed from the blood and passes into the hollow ?ber 
lumens to be removed by a sweep gas. From there, the oxy 
genated blood is returned to the patients bloodstream. It is for 
that reason that such devices are often termed “arti?cial 
lungs,” for their ability to replace or supplement the gas 
exchange function of the patient’s own lungs. 
Disadvantageously, conventional arti?cial lungs often pro 
vide uneven blood perfusion. This is because existing such 
devices typically include areas wherein blood ?ow becomes 
lessened or even stagnant. This causes thrombosis and in 
extreme cases device failure. In turn, a traditional arti?cial 
lung circuit consists of an oxygenator/arti?cial lung as 
described for gas exchange/oxygenation, a double lumen can 
nula or two separate cannulas for blood infusion/drainage 
into/from a patient, and a blood pump to drive the blood 
through the circuit. In a typical pneumatically driven pump, 
each pumping cycle includes a systolic phase (pushing blood 
from a pump blood chamber into a patient through an infusion 
cannula lumen) and a diastolic phrase (withdrawing blood 
from the patient into the pump blood chamber through a 
drainage cannula lumen). The systolic and diastolic phases of 
the pumping cycle are performed alternately, not simulta 
neously. Therefore, the infusion/drainage cannulae can only 
move blood during 50% of the pumping cycle. This requires 
twice the blood ?ow rate and twice the driven pressure/ delta 
p to move the same amount of blood compared to a pump 
cycle where the systolic and diastolic phases could be per 
formed simultaneously. For this reason, a relatively larger 
sized cannula is needed to move the same amount of blood as 
would be possible if the cannulae could move blood for a 
greater percentage of the pumping cycle, which is disadvan 
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tageous in situations requiring peripheral cannulation, since 
the cannula size is strictly limited by the size of the blood 
vessel to be cannulated. 
To solve this and other problems, the present disclosure 
provides a compact hollow ?ber membrane blood oxygenator 
including an integral pneumatic pump and blood ?ow redi 
rector structures, eliminating the need for a separate pump 
and so simplifying the arti?cial lung circuit. The present 
disclosure also provides such an oxygenator including an 
additional pneumatic pump serving as an atrium, to the oxy 
genator pump inlet, allowing withdrawal from and pumping 
blood to a patient to occur simultaneously, increasing e?i 
ciency of the arti?cial lung circuit and the infusion/drainage 
cannulae, and allowing use of cannulae having a reduced 
inner diameter compared to conventional cannulae. The 
device of the present disclosure provides an even blood ?ow 
pattern, preventing or reducing incidence of thrombosis. In 
turn, the presently disclosed design simpli?es the blood cir 
cuit and also provides a pulsatile blood ?ow pattern, promot 
ing active blood mixing and thereby improving gas exchange 
within the pump. The present device ?nds use at least in 
treatment of acute or chronic lung failure, as well as for 
combined right heart and lung (RVAD) failure. 
SUMMARY OF THE INVENTION 
The present disclosure provides a blood oxygenator for use 
as an arti?cial lung, in RVAD, and the like. The oxygenator 
includes an integral pneumatic pump enclosed substantially 
within a housing thereof, providing a compact and ef?cient 
design. Inlet blood redirectors and outlet blood collectors are 
provided, which in combination with the integral pneumatic 
pump promote an even perfusion of blood, eliminating areas 
of stagnation. 
In an embodiment, an atrium is provided at an inlet of the 
blood oxygenator. The atrium is de?ned by an additional 
pneumatic pump for promoting blood withdrawal from a 
patient body into the oxygenator by establishing a negative 
blood pressure. In this embodiment, the oxygenator pump 
described above functions substantially as a ventricle. The 
atrium pump and oxygenator pump are separately driven. 
During the bulk of the pumping cycle (for example, 80-95%), 
a positive pressure is applied to the oxygenator pump (ven 
tricle) to push blood into the patient via an infusion cannula 
and a simultaneous small negative pressure applied to the 
atrium withdraws blood from the patient via a drainage can 
nula. For the remainder of the pumping cycle (in the example, 
5-20%), a negative pressure is applied to the oxygenator 
pump (ventricle) and zero pressure is applied to the atrium, 
moving blood rapidly from the atrium to the ventricle By 
cyclically maintaining an internal pressure of the atrium 
pneumatic pump(s) at zero or less, a constant, even supply of 
blood from the patient is provided at the blood oxygenator 
inlet, thereby eliminating the pulsatile inlet blood ?ow pat 
terns provided by conventional pumping systems. 
In turn, a blood oxygenating system employing the blood 
oxygenator of the present disclosure is described, for remov 
ing blood from a patient body and returning blood to same. 
These and other embodiments, aspects, advantages, and 
features of the present invention will be set forth in the 
description which follows, and in part will become apparent 
to those of ordinary skill in the art by reference to the follow 
ing description of the invention and referenced drawings or by 
practice of the invention. The aspects, advantages, and fea 
tures of the invention are realized and attained by means of the 
instrumentalities, procedures, and combinations particularly 
pointed out in the appended claims. Unless otherwise indi 
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cated, any references discussed herein are speci?cally incor 
porated by reference in their entirety into the present disclo 
sure. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying drawings incorporated in and forming 
a part of the speci?cation, illustrate several aspects of the 
present invention, and together with the description serve to 
explain the principles of the invention. In the drawings: 
FIG. 1 shows a housing for the oxygenator of the present 
disclosure; 
FIG. 2 shows a cross-sectional side view of the oxygenator; 
FIG. 3 shows an inlet blood ?ow redirector for the oxygen 
ator; 
FIG. 4 graphically shows blood ?ow through the present 
oxygenator (right ?gure) versus a conventional oxygenator 
(left ?gure); 
FIG. 5 shows graphically shows blood ?ow pressure con 
tours for the present oxygenator (right ?gure) versus a con 
ventional oxygenator (left ?gure); 
FIG. 6 shows a top view of the oxygenator of the disclo 
sure; 
FIG. 7 shows a cross-sectional side view of the oxygenator, 
including an integrated pneumatic pump; 
FIG. 8 shows the oxygenator of FIG. 7 in systolic phase; 
FIG. 9 shows the oxygenator of FIG. 7 in diastolic phase; 
FIGS. 10a and 10b show the oxygenator including an 
atrium, in diastolic phase (FIG. 10a) and in systolic phase 
(FIG. 10b); and 
FIG. 11 graphically presents relative internal pressures of 
the atrium and oxygenator in systolic and diastolic phases. 
DETAILED DESCRIPTION OF THE 
ILLUSTRATED EMBODIMENTS 
In the following detailed description of the illustrated 
embodiments, reference is made to the accompanying draw 
ings that form a part hereof, and in which is shown by way of 
illustration, speci?c embodiments in which the invention may 
be practiced. These embodiments are described in su?icient 
detail to enable those skilled in the art to practice the inven 
tion. Also, it is to be understood that other embodiments may 
be utilized and that process, reagent, software, and/or other 
changes may be made without departing from the scope of the 
present invention. 
In one aspect, the present disclosure provides a blood oxy 
genator 10 (see FIG. 1) including a housing 12, at least one 
blood inlet 14. and at least one blood outlet 16. At least one 
sweep gas inlet 18 and at least one sweep gas outlet 20 are 
provided for supplying a gas to and removing same from the 
oxygenator 10, typically with the sweep gas being passed 
through the oxygenator 10 in a direction opposite that of the 
blood ?ow. For as exchange, a hollow ?ber membrane array 
22 is provided, using membranes as are known in the art. 
Arrays 22 of membranes may be provided arranged substan 
tially parallel to a longitudinal axis of the oxygenator 10 
housing 12, or alternatively diagonal spirally wound mem 
brane arrays 22 (FIG. 2) may be provided. Each such structure 
is well known in the art. Inlet potting 24 and outlet potting 26 
are provided and disposed to prevent entry of blood into the 
lumens of the hollow ?bers of the membrane arrays 22, also as 
are known in the art. The inlet potting 24 may de?ne an 
inverted dome shape, further assisting in promoting even 
redistribution of blood passing through the oxygenator 10. 
The system 10 of the invention further includes blood ?ow 
redirector structures, providing an even blood ?ow pattern as 
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blood passes through the oxygenator 10. An inlet blood ?ow 
redirector 28 is provided at an end of the oxygenator 10 distal 
from the blood inlet 14 for evenly redirecting blood ?ow 
passing through the blood inlet 14. In an embodiment, a 
frusto-conical inlet blood ?ow redirector 28 is provided at a 
distal end of the blood inlet 14 (see FIG. 3), secured to or 
molded with the distal end of the blood inlet 14 by one or more 
columns 30. At least a portion of the conical inlet blood ?ow 
redirector 28 is disposed in an interior of the blood inlet 14 
distal end. Like structures are described in copending US. 
Published Patent Appl. No. 2013/0211483, ?led concurrently 
herewith and incorporated herein in its entirety by reference. 
As shown in FIG. 2, the inlet blood ?ow redirector 28 
promotes even radial perfusion across a surface of the inlet 
potting 24 at a bottom of the oxygenator and also even axial 
blood ?ow as blood travels through the oxygenator 10 
towards the blood outlet 16 (see arrows), eliminating stagnant 
blood ?ow in the oxygenator 10. 
In turn, a blood collection channel 32 is provided at atop of 
the oxygenator 10, whereby blood exiting the membrane 
array 22 is collected and redirected to the blood outlet 16 (see 
FIG. 6). A substantially crescent-shaped blood collection 
channel 32 is shown, although the skilled artisan will appre 
ciate that other cross-sectional shapes are possible and con 
templated, such as segmental, triangular, etc. The blood col 
lection channel 32 regulates blood ?ow evenly at the outlet 
end of the oxygenator 10, and further guides blood to the 
blood outlet 16. That is, blood enters via the blood inlet 14 and 
is evenly redirected by the inlet blood ?ow redirector 28 as 
summarized above to pass over the hollow ?ber membrane 
array 22. On exiting the membrane array 22, bloodpasses into 
the blood collection channel 32 and therefrom exits the oxy 
genator 10 via the blood outlet 16. In that manner, areas of 
stagnant blood ?ow at or near the blood outlet 16 are reduced 
or eliminated. 
Rather than utiliZing an external pump as is common with 
conventional oxygenators, the oxygenator 10 of the present 
disclosure includes an integral pneumatic pump to provide 
pumping action for passing blood from the blood inlet 14, 
over the hollow membrane array 22, and to the blood outlet 
16. As such, a compact, economical and ef?cient combination 
of pump and oxygenator is provided. Providing further 
advantages, the integral pneumatic pump provides a pulsatile 
blood ?ow pattern, promoting active blood mixing for 
improved gas exchange performance and an improved blood 
?ow pattern to reduce thrombogenicity. Because of that 
improved gas exchange performance, it is possible to provide 
a lesser gas exchange surface area compared to conventional 
oxygenators, allowing a more compact unit. 
With reference to FIG. 7, a cylinder 34 is disposed in an 
interior of the hollow membrane array 22. Within cylinder 34, 
a ?exible membrane 36 is disposed to de?ne a pneumatic 
pump 38. Pump inlet and outlet valves 40, 42, in an embodi 
ment being duck-bill valves of known con?guration, prevent 
other than a uni -directional blood ?ow through the pneumatic 
pump 38 (see arrows). 
A pump gas inlet/outlet 44 is connected to a pneumatic 
console (not shown) for providing gas to operate the pneu 
matic pump 38. Pump gas is cyclically supplied to and with 
drawn from the pump gas inlet outlet 44, causing the ?exible 
membrane 36 to expand and contract, providing a pumping 
action to promote blood ?ow. As shown in FIGS. 8 and 9, 
when gas is supplied to the pump gas inlet outlet 44 (systole), 
the ?exible membrane 36 collapses, closing the pump inlet 
valve 40 and forcing blood out of the pneumatic pump 38 via 
the now open outlet valve 42 to perfuse through the hollow 
membrane ?ber array 22. When gas is withdrawn from the 
US 8,906,300 B2 
5 
pump gas inlet/outlet 44 (diastole), the ?exible membrane 36 
expands, closing the pump outlet valve 42 and opening the 
pump inlet valve 40, generating negative pressure and draw 
ing blood into the pneumatic pump 38 from the patient’ s body 
through the now-open pump inlet valve 40. On the next cycle, 
the blood is delivered from the pneumatic pump 38 as 
described above. 
In another aspect, an atrium 100 is provided which further 
improves pump performance and blood ?ow through the oxy 
genator 10 of the present disclosure (see FIGS. 10a and 10b). 
In an embodiment, the atrium 100 is de?ned by at least one 
additional pneumatic pump 102, disposed at or de?ning the 
blood inlet of the oxygenator 10. As shown, the at least one 
additional pneumatic pump 102 is con?gured substantially as 
described above for the integral pneumatic pump 38 of the 
oxygenator 10, including a pneumatic cylinder 104 and ?ex 
ible membrane 106, and a gas inlet/outlet 108. For conve 
nience and compactness, the atrium outlet valve may de?ne 
the inlet valve 40 for the oxygenator 10 integrated pneumatic 
pump 38, although of course the valve structures may be 
entirely separate. 
The atrium 100 operates in systolic and diastolic phases as 
described for the oxygenator 10 pneumatic pump 38. That is, 
cyclically supplying gas to the gas inlet/outlet 108 causes the 
atrium pneumatic pump 102 ?exible membrane 106 to 
expand and collapse, passing blood through the pneumatic 
pump 102 and into the oxygenator 10. 
In use, the atrium 100 is kept primarily in a state of negative 
internal pressure by withdrawal of gas, with the exception of 
a time immediately prior to the diastolic phase of the oxygen 
ator 10 pneumatic pump 38 (see FIG. 11). Typically, the 
atrium 100 internal pressure is substantially zero at the high 
est, i.e. during diastole. This is accomplished by intermit 
tently discontinuing withdrawal of gas from the atrium 100 
(as distinguished from af?rmatively supplying gas to the 
atrium 100 pneumatic pump 102). In contrast, the oxygenator 
10 pneumatic pump 38 is provided only a very short phase of 
negative internal pump pressure (see FIG. 11). In diastole, 
when an internal pres sure of the atrium 100 pneumatic pump 
102 is highest, an internal pressure of the oxygenator 10 
pneumatic pump 38 is made slightly negative by withdrawal 
of gas (see FIG. 11). 
By this design, the skilled artisan will appreciate that a 
consistent ?ow of blood is established into the inlet of the 
oxygenator 1 0 compared to the pulsatile and irregular entry of 
blood into oxygenators established by conventional designs. 
This is because the internal pressure of the atrium 100 into 
which blood ?rst ?ows is almost always negative and blood is 
almost always draining from the patient and into the atrium. 
In turn, very little resistance is imposed to transfer of blood 
from the atrium 100 into the oxygenator 10 to ?ll the pneu 
matic pump 38, since when pump gas is withdrawn from the 
oxygenator 10 pneumatic pump 38 (diastole, see FIGS. 10a 
and 11), the internal pressure of the atrium 100 is zero at its 
highest, i.e. slightly higher than the internal pressure of the 
oxygenator 10 pneumatic pump 38. By this mechanism, 
transfer of blood from the atrium 100 to the oxygenator 10 
pneumatic pump 38 is promoted by that slight pressure dif 
ferential. These differentials are shown graphically in FIG. 
11. Of course, the more even and non-pulsatile blood ?ow 
pattern established between the atrium 100 and the oxygen 
ator 10 achieved by the present mechanism should not be 
confused with the pulsatile ?ow established forblood passing 
through the oxygenator 10 via the oxygenator pneumatic 
pump 38, for the bene?ts described above. 
The present oxygenator 10 will typically be supplied with 
blood from a patient’s body by a cannula. A dual lumen 
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cannula such as those described in Us. Pat. No. 7,473,239 
and/or U.S. Published Patent Appl. No. US 2011/0040241 is 
preferred, which both passes blood from a patient’s body via 
a withdrawal cannula into the oxygenator 10 andpasses blood 
back into the patient’s body via a delivery cannula. This has 
the further advantage of reducing the length of the de?ned 
blood ?ow circuit, and eliminates multiple and potentially 
dangerous (to the patient) cannulations. 
There is accordingly provided by the present disclosure an 
oxygenator 10 which provides a pulsatile, evenly dispersed 
blood ?ow therethrough, augmenting gas exchange perfor 
mance and in turn allowing a lessened gas exchange surface 
area. The oxygenator 10 may include an atrium 100 de?ned 
by one or more additional pneumatic pumps 102, for regulat 
ing and providing an even blood supply from a patients’ 
circulatory system into the oxygenator 10. The oxygenator 10 
?nds use in a variety of procedures, including arti?cial lung 
applications and RVAD applications. Unlike conventional 
oxygenator designs, the present oxygenator 10 reduces or 
eliminates regions of stagnant or limited blood ?ow leading to 
thrombosis and device occlusion failure, and further provides 
a pulsatile ?ow which also decreases stagnant blood ?ow and 
reduces thrombogenicity. 
In turn, the integrated pump design of the oxygenator 10 
provides a compact, ef?cient design which improves patient 
comfort and mobility, and which also reduces risk of compli 
cating factors such as sepsis and the like resulting from 
replacing the devices repeatedly. The combined integrated 
pump/ arti?cial lung design simpli?es the PAL circuit in that 
only one component is provided in the circuit, and further 
increases pump ef?ciency by eliminating blood ?ow resis 
tance from connections between the pump and the arti?cial 
lung. 
One of ordinary skill in the art will recognize that addi 
tional embodiments of the invention are also possible without 
departing from the teachings herein. This detailed descrip 
tion, and particularly the speci?c details of the exemplary 
embodiments, is given primarily for clarity of understanding, 
and no unnecessary limitations are to be imported, for modi 
?cations will become obvious to those skilled in the art upon 
reading this disclosure and may be made without departing 
from the spirit or scope of the invention. Relatively apparent 
modi?cations, of course, include combining the various fea 
tures of one or more ?gures or examples with the features of 
one or more of other ?gures or examples. 
What is claimed is: 
1. A blood oxygenator, comprising: 
a housing, a blood inlet, a blood outlet, a sweep gas inlet, 
and a sweep gas outlet; 
a hollow membrane ?ber array disposed within an interior 
of the housing for gas exchange to and from blood pass 
ing through the oxygenator; 
an inlet blood ?ow redirector for evenly dispersing blood 
passing through the blood inlet through a distal end of 
the oxygenator, the inlet blood ?ow redirector including 
a conical tip extending into an interior lumen of a distal 
end of the blood inlet; 
an outlet blood ?ow collector for collecting blood exiting 
the hollow membrane array prior to exiting the oxygen 
ator via the blood outlet; and 
an integrated pneumatic pump disposed substantially 
within a perimeter de?ned by the housing, further 
wherein the integrated pneumatic pump is disposed in an 
interior of the hollow ?ber membrane array. 
2. The oxygenator of claim 1, wherein the inlet blood ?ow 
redirector de?nes a substantially frusto-conical shape and is 
disposed at an end of the housing distal to the blood inlet. 
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3. The oxygenator of claim 1, wherein the outlet blood 
collector de?nes a channel for guiding blood to the blood 
outlet. 
4. The oxygenator of claim 1, wherein the oxygenator 
pneumatic pump is de?ned by a cylinder centrally disposed 
within the hollow membrane ?ber array and further including 
an interior ?exible membrane and one or more valves for 
establishing a unidirectional blood ?ow by way of a cyclical 
supply of a pump gas. 
5. The oxygenator of claim 4, wherein the valves are uni 
directional valves disposed at an entry and at an exit of the 
?exible membrane for maintaining a unidirectional blood 
?ow. 
6. The oxygenator of claim 1, further including another 
pneumatic pump provided in an atrium disposed at the blood 
inlet. 
7. The oxygenator of claim 6, further including an atrium 
cyclical gas supply which maintains the atrium at an internal 
pressure of up to zero. 
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8. A blood oxygenator, comprising: 
a housing, a blood inlet, a blood outlet, a sweep gas inlet, 
and a sweep gas outlet; 
a hollow membrane ?ber array disposed within an interior 
of the housing for gas exchange to and from blood pass 
ing through the oxygenator; and 
an integrated pneumatic pump disposed substantially 
within a perimeter de?ned by the housing, further 
wherein the integrated pneumatic pump is disposed in an 
interior of the hollow ?ber membrane array; and 
another pneumatic pump provided in an atrium disposed at 
the blood inlet. 
9. The blood oxygenator of claim 8, further including an 
atrium cyclical gas supply which maintains the atrium at an 
internal pressure of up to zero. 
* * * * * 
